Emergency Department-based monoclonal antibody therapy for patients with mild to moderate COVID-19

OBJECTIVES: To describe the implementation of an ED-based program to offer monoclonal antibody therapy to patients with mild-moderate COVID-19 disease. BACKGROUND: Monoclonal antibody therapy (MOAB) has recently emerged as a treatment for mild to moderate COVID-19, potentially preventing those with...

Descripción completa

Detalles Bibliográficos
Autores principales: Devlin, Amanda, O'Neill, Ann, Anthoney, C., Lim, E., Simms, Charmaine, Eiting, Erick, Nunez, Jeranil, Farraj, Rowaida, Koshy, Sanjana, Calderon, Yvette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069988/
http://dx.doi.org/10.1016/j.jemermed.2023.03.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069988/
http://dx.doi.org/10.1016/j.jemermed.2023.03.006

Ejemplares similares